• Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor

€0.0

round
investor

€0.0

round
investor investor investor investor

€0.0

round
investor investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor

€0.0

Valuation: €0.0

2436.8x EV/Revenue

-30.3x EV/EBITDA

round
*

N/A

Late VC
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP2017201820192020202120222023
Revenues0000000000000000000000000000
% growth-----(98 %)1991 %
EBITDA0000000000000000000000000000
% EBITDA margin----(1535 %)(168106 %)-
Profit0000000000000000000000000000
% profit margin----(912 %)(150608 %)(142 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

Notes (0)
More about ENOUGH
Made with AI
Edit

ENOUGH, formerly known as 3F BIO, is a food technology company founded in Glasgow, Scotland, in 2015 by Jim Laird, David Ritchie, and Craig Johnson. The founders combined their backgrounds in the food industry and chemical engineering to address the challenge of sustainable protein production for a growing global population. The company's core mission is to make protein sustainable through a zero-waste fermentation process.

The company produces ABUNDA® mycoprotein, a food ingredient derived from fermenting fungi with sugars from renewable feedstocks like grains. This process is significantly more resource-efficient than traditional animal protein production, using substantially less water and feed while generating fewer CO2 emissions. The resulting mycoprotein is a whole food ingredient rich in protein and fiber, containing all nine essential amino acids. It has a neutral taste and a fibrous, meaty texture, making it a versatile component for developing alternatives to meat, fish, and dairy products.

ENOUGH operates on a business-to-business (B2B) model, supplying its ABUNDA® ingredient to food manufacturers, retailers, and food service companies. This strategy aims to accelerate the adoption of sustainable protein by enabling other companies to expand their plant-based product lines. The company has a production facility in Sas van Gent, Netherlands, strategically co-located with a Cargill facility that supplies the necessary glucose feedstock. ENOUGH has an ambitious goal to produce one million tonnes of mycoprotein cumulatively by 2032.

The company has successfully raised significant capital to fund its expansion, with total funding surpassing €110 million from multiple rounds. Key investors include CPT Capital, Nutreco, Cargill, World Fund, and Scottish Enterprise. These investments are being used to scale up production capacity to meet the increasing demand from the alternative protein market.

Keywords: mycoprotein, food technology, sustainable protein, B2B ingredients, fermentation, alternative protein, food production, plant-based, food sustainability, ABUNDA, fungi-based protein, meat substitute, food ingredient, zero-waste, food-tech, sustainable food, vegan protein, eco-friendly food, food innovation, biotechnology

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo